Notes archive.
Kaveri Seed's FY26 profit grows 6.8% on 16% higher revenue
Annual results are in line with prior trends. A auditor flag on a foreign subsidiary's going-concern status is a known issue with minimal consolidated impact.
Asahi Songwon passes CEO role to founder's son as revenue slips
Consolidated revenue fell 4.8% in FY26. The company's founder stepped down as CEO, handing the role to his son.
Shilpa Medicare drops Aflibercept Europe trial, delays alopecia drug
The company shelved a costly European trial for one biologic and pushed back a Phase I for another, even as Q4 FY26 hit record revenue.
Grauer & Weil FY26 results show moderate growth; ₹0.50 dividend steady
Audited annual results are in line with prior guidance. The mall suspension remains an overhang on the business.
Goodluck India recommends ₹3 dividend, but the numbers aren't here yet
The board approved FY26 results and a final payout. The actual financials remain a separate filing.
Carnation needs to raise ₹50 cr. That's 172% of its own market cap.
The nano-cap is issuing new equity worth more than the company to meet SEBI's public-float rule and fund operations.
Solarworld's ₹1,202 cr FY26 revenue confirmed, but the news is already priced in
Audited results formalize numbers from May 1. The company's revenue more than doubled year-on-year.
Marksans closes FY26 with record ₹3,033 cr revenue as Q4 UK sales hit all-time high
Full-year profit rose 9.8% to ₹420 crore. The fourth quarter accelerated, with UK sales at a record and Australia/New Zealand revenue doubling sequentially.
ITCONS wins ₹3.37 cr Delhi Police contract, its third government order this year
The manpower outsourcing deal crosses the 1% materiality threshold for the ₹325 cr market-cap company, adding to recent defence and agriculture ministry orders.
Elin's Ghaziabad plant shuts after fire, insurer to assess damage
A section of the factory is temporarily closed, though other operations continue. The company says assets are adequately insured.
Eiko Lifesciences revenue jumps 124% in Q4
The company reported a strong finish to FY26 with standalone revenue growth of 124% YoY for the quarter and a doubling of net profit.
Entero Healthcare cuts GLP-1 market share estimate by half
Management revised its GLP-1 market share to 5% from 10% and corrected its FY26 acquisition count during a post-results conference call.
Solarworld revenue doubles to ₹1,202 cr as project execution ramps up
Standalone revenue surged 120% in FY26, while the board appointed managing director Kartik Teltia as chairman following a director's resignation.
Aarti Pharmalabs profit drops as finance costs and margins bite
The pharmaceutical firm reported a decline in annual profit to ₹176.20 crore, down from ₹238.03 crore in the previous year.
Genus Paper profit jumps 80% on accounting change and asset sale
Net profit reached ₹14.58 crore for FY26, aided by a ₹4.30 crore reduction in depreciation and the divestment of a subsidiary.
Seamec hits record revenue of ₹1,000 cr but warns of stranded vessel
The company posted its highest-ever annual profit of ₹253 crore, yet the Seamec Paladin remains stuck in Dubai due to regional conflict.
PI Industries earnings transcript adds no new material information
The transcript for Q4 and FY26 results repeats guidance and operational updates already disclosed to the market.
Royal Orchid Hotels misses revenue target and pulls long-term guidance
The hotel chain reported FY26 revenue of ₹384 crore, missing its own ₹420 crore target, and wrote off ₹5.5 crore at its Mumbai flagship.
Marksans Pharma profit jumps 60% on standalone basis for FY26
Standalone net profit reached ₹3,007 million as revenue climbed 14%. Consolidated profit grew at a more modest 10% to ₹4,201 million.
Mahamaya Lifesciences releases FY26 audited results
The company confirms previously disclosed annual figures of ₹328.87 crore in revenue and ₹16.52 crore in profit.
Goodluck India reports steady profit growth for FY26
The company posted a 10.2% rise in consolidated net profit to ₹182.58 crore and declared a final dividend of ₹3 per share.
Global Infratech & Finance plans to borrow ₹50 cr, 10x its market cap.
The board approved a borrowing limit of ₹50 crore for a company with a market capitalisation of just ₹5 crore. The proposal now heads to a shareholder vote.
Tomorrow Technologies revenue drops 92% as it pivots to AI
Revenue fell to ₹33.57 lacs from ₹442.18 lacs as the company shuttered its equity segment. Losses narrowed on a standalone basis but widened on a consolidated level.
Genus Paper & Boards profit jumps 80% as fire hits stockyard
Annual profit reached ₹14.58 crore on revenue of ₹939.97 crore, even as a late-May fire damaged raw material inventories at the Muzaffarnagar unit.
Ambika Cotton Mills reports steady growth in FY26 results
The company posted an 11.2% rise in annual revenue to ₹780.95 crore, maintaining a stable dividend payout of ₹37 per share.